Associate Professor Christina Brown

Clinical Associate Professor
Medicine, Central Clinical School

Telephone +61 2 9515 8031

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Li, Z., Ju, X., Lee, K., Clarke, C., Hsu, J., Abadir, E., Bryant, C., Pears, S., Sunderland, N., Heffernan, S., Lo, T., Fromm, P., Silveira, P., Cooper, W., Brown, C., Clark, G., Hart, D., et al (2018). CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma. Haematologica, 103(4), 655-665. [More Information]
  • Yeung, J., Vaughan, E., Chadban, S., Saunders, J., Thiagarajah, N., Brown, C. (2018). High-dose intravenous methotrexate with high-flux, extended-hours haemodialysis in treatment of primary central nervous system, post-transplant lymphoproliferative disorder and end-stage kidney disease: A case report. Nephrology, 23(11), 1063-1064. [More Information]

2018

  • Li, Z., Ju, X., Lee, K., Clarke, C., Hsu, J., Abadir, E., Bryant, C., Pears, S., Sunderland, N., Heffernan, S., Lo, T., Fromm, P., Silveira, P., Cooper, W., Brown, C., Clark, G., Hart, D., et al (2018). CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma. Haematologica, 103(4), 655-665. [More Information]
  • Yeung, J., Vaughan, E., Chadban, S., Saunders, J., Thiagarajah, N., Brown, C. (2018). High-dose intravenous methotrexate with high-flux, extended-hours haemodialysis in treatment of primary central nervous system, post-transplant lymphoproliferative disorder and end-stage kidney disease: A case report. Nephrology, 23(11), 1063-1064. [More Information]

To update your profile click here. For support on your academic profile contact .